Creative BioMart Scholarship Program

As a leading supplier of a wide range of biological products including recombinant proteins, native proteins, cell/tissue lysates, etc. and a high-quality custom service provider specializing in academic research, diagnostic and therapeutic applications as well as industry requirements, Creative BioMart always strives to support young and ambitious talents in our field.
To further support their research and higher education in the biomedical and science fields, Creative BioMart is proud to announce the 2024 Scholarship Program, which will award $1,000 to an outstanding college student.
Thanks for your interest in the 2024 Creative BioMart Scholarship Program!

Requirements
The Creative BioMart scholarship is open on a global basis. To be eligible to receive a scholarship, you must meet the following requirements:

Enrolled as an undergraduate, graduate or Ph.D. student at an accredited college, university or research Institute.
Major in Biology, Biochemistry, Molecular Biology, Biotechnology or a related major.
Can provide proof of a good average grade with at least a B (GPA 3.0/4.0).

Required application documents
Application form
Letter of recommendation (from a teacher, mentor, school counselor, or community leader)
Current certificate of enrollment
Current transcript of records with average grade score
Tabular resume
A summary of your Bachelor’s thesis / Master’s thesis, or other project
A written essay of at least 800 words or a PowerPoint presentation of 10–12 pages with detailed presentation notes, which must be completely original, grammatically correct, and demonstrate your originality, creativity, clarity, and coherence. The topic and requirement are as follows:
A Recombinant Protein
Protein Therapeutics
Recombinant Protein related Technology
Outline recommendation: (Any better idea than the above three aspects is welcome in your essay.)

Introduction to the proteins / therapeutic methods / technology (definition, classification, history, principle, development, etc.).
Products under development and already on the market.
Clinical, scientific or industrial applications of these proteins / therapeutic methods / technology.
Your opinion on their prospects.